Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Joseph A Salami"'
Publikováno v:
Journal of the American College of Cardiology. 81:1502-1504
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0fb5b721abb1e599713db83615e7142
https://doi.org/10.1016/j.jacc.2023.02.028
https://doi.org/10.1016/j.jacc.2023.02.028
Autor:
Khurram Nasir, Joseph A. Salami
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 15
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa69b39df0d0355c082216c2b4c5c19e
https://doi.org/10.1161/circoutcomes.122.009399
https://doi.org/10.1161/circoutcomes.122.009399
Autor:
Jai Singh, Javier Valero‐Elizondo, Joseph A. Salami, Haider J. Warraich, Oluseye Ogunmoroti, Erica S. Spatz, Nihar Desai, Jamal S. Rana, Salim S. Virani, Ron Blankstein, Michael J. Blaha, Khurram Nasir
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 9 (2018)
BackgroundAtherosclerotic cardiovascular disease (ASCVD) and cancer are among the leading causes of economic burden, morbidity, and mortality in the United States. We aimed to quantify the overall impact of cardiovascular modifiable risk factor (CRF)
Externí odkaz:
https://doaj.org/article/3449000e7aa54ae78f91a6f63793849e
Autor:
Joseph A. Salami, Haider J. Warraich, Javier Valero‐Elizondo, Erica S. Spatz, Nihar R. Desai, Jamal S. Rana, Salim S. Virani, Ron Blankstein, Amit Khera, Michael J. Blaha, Roger S. Blumenthal, Barry T. Katzen, Donald Lloyd‐Jones, Harlan M. Krumholz, Khurram Nasir
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 2 (2018)
BackgroundEvidence supporting nonstatin lipid‐lowering therapy in atherosclerotic cardiovascular disease risk reduction is variable. We aim to examine nonstatin utilization and expenditures in the United States between 2002 and 2013. Methods and Re
Externí odkaz:
https://doaj.org/article/7b0c446ad2fe412087fc72a4114652f9
Autor:
Joseph A. Salami, Javier Valero‐Elizondo, Oluseye Ogunmoroti, Erica S. Spatz, Jamal S. Rana, Salim S. Virani, Ron Blankstein, Adnan Younus, Alejandro Arrieta, Michael J. Blaha, Emir Veledar, Khurram Nasir
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 6 (2017)
BackgroundAtherosclerotic cardiovascular disease (ASCVD) causes most deaths in the United States and accounts for the highest healthcare spending. The association between the modifiable risk factors (MRFs) of ASCVD and pharmaceutical expenditures are
Externí odkaz:
https://doaj.org/article/c009278656544508985629df7bd262b4
Autor:
Javier Valero‐Elizondo, Joseph A. Salami, Chukwuemeka U. Osondu, Oluseye Ogunmoroti, Alejandro Arrieta, Erica S. Spatz, Adnan Younus, Jamal S. Rana, Salim S. Virani, Ron Blankstein, Michael J. Blaha, Emir Veledar, Khurram Nasir
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 5, Iss 9, Pp n/a-n/a (2016)
Background Physical activity (PA) has an established favorable impact on cardiovascular disease (CVD) outcomes and quality of life. In this study, we aimed to estimate the economic effect of moderate‐vigorous PA on medical expenditures and utilizat
Externí odkaz:
https://doaj.org/article/dd73fdf660f54aa68fccb5ef450ec886
Autor:
Timothy M. Pawlik, Erin D. Michos, Victor Okunrintemi, Michael J. Blaha, Martin Tibuakuu, Khurram Nasir, Oluseye Ogunmoroti, Javier Valero-Elizondo, Eve Marie Benson, Chukwuemeka U. Osondu, Joseph A Salami
Publikováno v:
J Gen Intern Med
BACKGROUND: Approximately 20% of patients with atherosclerotic cardiovascular disease (ASCVD) suffer from depression. OBJECTIVE: To compare healthcare expenditures and utilization, healthcare-related quality of life, and patient-centered outcomes amo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b941ae1108c06ab0e784d68d69f4748a
https://doi.org/10.1007/s11606-019-05325-8
https://doi.org/10.1007/s11606-019-05325-8
Autor:
Ron Blankstein, Rohan Khera, Javier Valero-Elizondo, Haider J. Warraich, Michael J. Blaha, Khurram Nasir, Timothy M. Pawlik, Salim S. Virani, Victor Okunrintemi, Erica S. Spatz, Harlan M. Krumholz, Kumar Dharmarajan, Joseph A Salami
Publikováno v:
Journal of General Internal Medicine. 34:884-892
Disparities in health outcome exist among patients according to socioeconomic status. However, little is known regarding the differences in healthcare experiences across the various levels of income of patients. In a nationally representative US adul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6f3c8c2d9effbd423cfec6d10df7be8
https://doi.org/10.1007/s11606-019-04848-4
https://doi.org/10.1007/s11606-019-04848-4
Autor:
Muni Rubens, Philipp Lacour, Florian Blaschke, Tobias Daniel Trippel, Peter McGranaghan, Emir Veledar, Danilo Obradovic, Hans-Dirk Düngen, Joseph A Salami, Anshul Saxena, Elvis Tahirovic, Burkert Pieske, Goran Loncar, Sandeep Appunni, Frank T. Edelmann
The Cardiac Lipid Panel (CLP) is a novel panel of metabolomic biomarkers that has previously shown to improve the diagnostic and prognostic value for CHF patients. Several prognostic scores have been developed for cardiovascular disease (CVD) risk, b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17e2bc264f541b0eba3469ff2e0fb60c
https://doi.org/10.21203/rs.3.rs-131137/v1
https://doi.org/10.21203/rs.3.rs-131137/v1
Publikováno v:
Circulation. 142
Background: FGF-23 is an endocrine regulator of phosphate metabolism as well as also a potent biomarker that mediates cardiovascular remodeling, with markedly elevated plasma concentration associated with the occurrence of morbid cardiovascular event
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f97ddd79637f9a5bd28d0004a7ec4709
https://doi.org/10.1161/circ.142.suppl_3.15859
https://doi.org/10.1161/circ.142.suppl_3.15859